Immix Biopharma, Inc.IMMXNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P60
Within normal range
vs 2Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 29.28% |
| 2023 | 108.19% |
| 2022 | 3216.11% |
| 2021 | -49.01% |
| 2020 | -57.45% |
| 2019 | 0.00% |